Stephens & Co. Maintains Overweight on Vertex, Lowers Price Target to $18

Benzinga Newsdesk www.benzinga.com Negative 86.8%

Neg 86.8% Neu 0% Pos 0%

Stephens & Co. analyst Brett Huff maintains Vertex (NASDAQ:VERX) with a Overweight and lowers the price target from $20 to $18.